Florida Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.

Press releases published on November 6, 2026

Nov. 6, 2026

Florida Injury Law Firm Warns Against Relying on AI for Personal Injury Claims

Indeterminate EIN Presswire

Nov. 6, 2026

Sonitor Wins Gold in 2026 Merit Healthcare Awards for Best Healthcare Management Solution

Indeterminate EIN Presswire

Nov. 6, 2026

Brantheo Launches Bilingual AI Receptionist for Central Florida Service Businesses

Indeterminate EIN Presswire

Nov. 6, 2026

The Difference Between Profits Management and Multi-Level Marketing Businesses

Indeterminate EIN Presswire

Nov. 6, 2026

Biofrontera Inc. to Report Third Quarter 2026 Financial Results on November 13, 2026

Indeterminate GlobeNewswire

Nov. 6, 2026

MediPharm Labs Sets Date to Report Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 6, 2026

Constellation Software Inc. Announces Results for the Third Quarter Ended September 30, 2026 and Declares Quarterly Dividend

Indeterminate GlobeNewswire

Nov. 6, 2026

Parker Scheduled to Present at Robert W. Baird Global Industrial Conference on November 10 at 10:50 a.m. Central Time (11:50 a.m. Eastern Time)

Indeterminate GlobeNewswire

Nov. 6, 2026

Surrozen to Present at Upcoming Healthcare Investor Conference

Indeterminate GlobeNewswire

Nov. 6, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Entera Announces Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 6, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Nov. 6, 2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

Nov. 6, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026

Indeterminate GlobeNewswire

Nov. 6, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire